Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trialJianxing He, Caicun Zhou, Chun Chen et al.|The Lancet Respiratory Medicine|2021Cited by 183
MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancerBing Li, Gerald Schmit-Bindert, Shengxiang Ren et al.|Lung Cancer|2013Cited by 178
Pan-cancer analysis of <i>ARID1A</i> Alterations as Biomarkers for Immunotherapy OutcomesTao Jiang, Caicun Zhou, Xiaoxia Chen et al.|Journal of Cancer|2019Cited by 142
Pretreatment neutrophil-to-lymphocyte ratio is associated with outcome of advanced-stage cancer patients treated with immunotherapy: a meta-analysisTao Jiang, Caicun Zhou, Meng Qiao et al.|Cancer Immunology Immunotherapy|2018Cited by 99
Correlation of long non-coding RNA <i>H19</i> expression with cisplatin-resistance and clinical outcome in lung adenocarcinomaQi Wang, Caicun Zhou, Ningning Cheng et al.|Oncotarget|2016Cited by 77